Related Experiment Video
Updated: Aug 29, 2025

14:32
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
23.8K
Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials
Epidemiologic Reviews
|September 6, 2022
Summary
Reporting clinical trial harms requires more than simple counts. Visualizations like dot plots and volcano plots better communicate multidimensional adverse event data, including severity and timing, to stakeholders.
Area of Science:
- Clinical Trials
- Data Visualization
- Pharmacovigilance
Background:
- Adverse events in clinical trials are typically reported by frequency counts, omitting crucial data dimensions like severity, seriousness, and timing.
- Current reporting methods fail to capture the full spectrum of harm information, hindering comprehensive stakeholder understanding.
- Existing reporting practices often exclude many observed harms due to selection criteria.
Purpose of the Study:
- To evaluate and compare six distinct data visualization techniques for reporting clinical trial harms.
- To assess the utility of visualizations in communicating multidimensional adverse event data.
- To identify optimal visualization methods favored by content experts for improved harm communication.
Main Methods:
- Replication and comparison of six harm visualization approaches: dot plot, stacked bar chart, volcano plot, heat map, treemap, and tendril plot.
- Utilized individual participant data from a gabapentin neuropathic pain randomized trial for binary event analysis.
- Assessed visualization value through a heuristic approach and expert content review, with figures generated using R.
Main Results:
- Visualizations can present multiple dimensions of harms, unlike frequency counts alone.
- Dot plots and volcano plots emerged as favored methods for summarizing overall harms data.
- Most visualization methods, except the tendril plot, do not necessitate individual participant data.
Conclusions:
- Data visualization significantly enhances the communication of multidimensional clinical trial harms.
- Dot plots and volcano plots are recommended for their effectiveness in summarizing and conveying adverse event information.
- Open-source R code is provided to facilitate the implementation of these visualization techniques by trialists.
Related Concept Videos
Hazard Ratio
221
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
221
Clinical Trials: Overview
3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
162
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
162
Comparing the Survival Analysis of Two or More Groups
261
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
261
Clinical Trials
7.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.0K
Kaplan-Meier Approach
235
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
235

